Engineered m2a macrophages for the treatment of osteoarthritis

HIGHLIGHTS

• who: Chi Liang from the Center, United States Washington State University have published the paper: Engineered M2a macrophages for the treatment of osteoarthritis, in the Journal: (JOURNAL)
• what: The authors also compared TNFR knock-out with IL-4 overexpression and their synergy in pre-experiment, and found that the combination of these two editing was more resistant to OASF . This study provides insights into the treatment of inflammatory joint diseases including OA.
• how: The source and identifier of reagents in this study are showed in Supplementary Table S1. The authors declare that the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.